On 19 May 2026, Beauty Farm Medical and Health Industry Inc. disclosed a Next Day Disclosure Return detailing the on-market repurchase of 20,000 ordinary shares on the Hong Kong Stock Exchange.
The shares were bought at prices ranging from HKD 19.26 to HKD 20.10, for a total consideration of approximately HKD 0.40 million. The transaction represents 0.008 % of the company’s issued share capital (excluding treasury shares) immediately before the repurchase.
Following the buyback, issued shares outstanding fell to 249.45 million, while treasury shares increased to 2.14 million. Total issued shares remain unchanged at 251.59 million.
The purchase was made under the share-repurchase mandate granted on 27 June 2025, which authorises the company to buy back up to 23.58 million shares. Cumulative repurchases under this mandate now stand at 2.14 million shares, equivalent to 0.91 % of the shares outstanding on the mandate date.
In line with Hong Kong listing rules, a 30-day moratorium on new share issues or treasury-share disposals is in effect until 18 June 2026.
Comments